Here at Glen Allergy & Asthma, we place top priority on the health and safety of our patients, staff, and their families. We are open to serve you and your children, and we have instituted the following special practices and protocol to keep everyone safe:
- We promote social distancing.
- We require universal masking for all patients and staff.
- All patients and staff are screened for COVID-19 symptoms before entering the office, as well as during the scheduling process.
- We have added time between appointments to limit the number of patients in the office at a time.
- Whenever possible, we bring patients back directly to the exam room to minimize use of the waiting area.
- We ask parents to limit the number of people coming to our office to one healthy adult and one patient.
- All exam rooms are thoroughly sanitized between each patient visit. High-touch areas are cleaned and disinfected frequently throughout the day.
- Hand sanitizer is readily available to patients and staff throughout our office.
- Magazines, books, toys, and other materials that cannot be cleaned properly have been removed.
- We are conducting telemedicine visits (televisits) whenever possible and is necessary. Televisits are performed on an encrypted, HIPAA-compliant, video-conferencing platform.
UPDATE:
Beginning May 18th, we will begin seeing certain types of visits in the office. Please call us to discuss you or your child's symptoms so that we can determine whether a telemedicine or in-person visit is needed.
Administration of allergy shots and biologic medications for asthma, eczema, and hives will continue with these escalated precautions. This includes having patients call the office upon arrival to our parking lot and before entering the office, at which time they will be given further instructions.
If you are unwell, have a fever, or are showing signs of an upper respiratory infection, such as cough or difficulty breathing, please stay home, and call the office for further instructions.
If you have traveled (within the US or internationally) within the last 14 days, we ask that you call and reschedule your appointment as a self-quarantine is recommended after international travel.
For additional information on COVID-19, please visit the CDC website at: https://www.cdc.gov/coronavirus/2019-ncov/summary.html
If you have any additional questions concerning your appointment, please feel free to contact our office at 847-832-6000.
Thank you for your patience and understanding. We are here for you during these unprecedented times.
- The Staff at Glen Allergy & Asthma
About Us
Conditions We Treat
First FDA-Approved Treatment for Peanut Allergy
Conditions We Treat
Year-round and seasonal nasal allergies
Eye allergies
Swollen eyes, itchy eyes, red eyes
Asthma
Wheezing, shortness of breath
Chronic sinusitis
Nasal polyps
Sampter's Triad, AERD, Aspirin Allergy
Anaphylaxis
Food allergies
Food oral desensitization (OIT)
Chronic cough
Hives and Angioedema (including Hereditary Angioedema)
Itching, swelling
Familial Cold Autoinflammatory Syndrome (FCAS)
Eczema (Atopic Dermatitis)
Medication reactions (Antibiotics/Penicillin, Aspirin)
Contact Dermatitis (Metal, nickel, cosmetics, hair dye)
Chronic itching
Recurrent infections
Venom allergy (bee/wasp/hornet)
Mast Cell Disorders
ABOUT US
First FDA-Approved Treatment for Peanut Allergy
Conditions We Treat
Glen Allergy & Asthma is a practice of Board Certified Allergists & Immunologists committed to providing the highest level of care for pediatric and adult patients suffering from allergic, asthmatic and immunologic disorders. Our state-of-the-art office is conveniently located in The Glen development between Lake Street and Willow Road in Glenview. We have affiliations with the NorthShore University Hospital System and Northwestern Medicine. Because we are independent providers, we are able to provide top-notch, personalized care without the hidden facility fees that you may experience with care at larger institutions.
First FDA-Approved Treatment for Peanut Allergy
First FDA-Approved Treatment for Peanut Allergy
First FDA-Approved Treatment for Peanut Allergy
Palforzia [Peanut (Arachis hypogaea) allergen powder)] has just gained FDA-approval for the treatment of peanut allergy. This is the first oral immunotherapy product approved in the US for desensitization to peanut in patients aged 4 through 17 years. Palforzia is approved for use in patients with a confirmed diagnosis of peanut allergy and is indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.
Here at GAA, we are poised to provide this innovative therapy to our patients. We are currently in the 2nd year of treating patients with peanut oral immunotherapy (OIT). This novel therapy provides much needed protection and peace of mind for patients and families.
We recommend patients make an appointment to see our physicians for an initial assessment. Considering peanut OIT requires a shared decision-making process with the patient, family and physician. Our practice will help guide patients to the best individual treatment plan.
We have devoted special OIT clinic times to help cater to the high demand of these treatments. Our staff is well-trained in caring for OIT patients.
If you would like to discuss peanut OIT, please call us to schedule a consultation at 847-832-6000.
You can check out more information at https://www.palforzia.com/.